PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

46 hedge funds and large institutions have $82.4M invested in PDS Biotechnology in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+14
Holders Change %
+43.75%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
26
Increased
10
Reduced
4
Closed
12
Calls
$2.75M
Puts
$3.9M
Net Calls
-$1.15M
Net Calls Change
-$1.15M

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$18.8M
2
BlackRock
2
BlackRock
New York
$5.04M
3
WVP
3
Worth Venture Partners
New Jersey
$4.38M
4
EI
4
EAM Investors
California
$3.51M
5
EGI
5
EAM Global Investors
California
$2.36M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$5.72M
2
IC
2
Ikarian Capital
Texas
$0
3
TRCT
3
Tower Research Capital (TRC)
New York
$40K
4
MWM
4
Minot Wealth Management
Massachusetts
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LNC
51
Lincoln National Corp
Pennsylvania
– -$76K -16,647 Closed
VF
52
Virtu Financial
New York
– -$48K -10,602 Closed
Cetera Investment Advisers
53
Cetera Investment Advisers
Illinois
– -$48K -10,500 Closed
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
– -$18K -4,000 Closed
TCWM
55
Total Clarity Wealth Management
Illinois
– -$7K -1,500 Closed
1 2
3